Comment on Dawed et al. Genome-Wide Meta-Analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673

Comment on Dawed et al. Genome-Wide Meta-Analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682

Published:2022-03-29 Issue:4 Volume:45 Page:e80-e81
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Wang Ke¹,Shi Mai¹,Yang Aimin¹,Tomlinson Brian¹²,Chan Juliana C.N.¹³⁴,Chow Elaine¹⁴⁵^ORCID

Affiliation:

1. Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

2. Faculty of Medicine, Macau University of Science and Technology, Macau, China

3. Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

4. Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

5. Phase 1 Clinical Trial Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/45/4/e80/672596/dc212428.pdf

Reference4 articles.

1. Genome-wide meta-analysis identifies genetic variants associated with glycemic response to sulfonylureas;Dawed;Diabetes Care,2021

2. SLCO1B1 variants and statin-induced myopathy—a genomewide study;Link;N Engl J Med,2008

3. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update;Ramsey;Clin Pharmacol Ther,2014

4. CYP2C19 loss-of-function polymorphisms are associated with reduced risk of sulfonylurea treatment failure in chinese patients with type 2 diabetes;Wang;Clin Pharmacol Ther,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes;Internet of Things and Machine Learning for Type I and Type II Diabetes;2024

2. Evaluating gliclazide for the treatment of type 2 diabetes mellitus;Expert Opinion on Pharmacotherapy;2022-11-10

3. Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682;Diabetes Care;2022-03-29